Prelude Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +33.3% | +922.3% | +36.5% | -27.7% | +25.9% | -36.8% | -19.5% | |
| – | +29.7% | +991.8% | +33.7% | -30.7% | +15.3% | -42.3% | -22.2% | |
| – | +21.1% | +1,056.4% | -85.4% | -3.8% | -17.4% | -50.7% | +182.6% | |
| – | +21.1% | +1,056.4% | +33.4% | -30.7% | +15.5% | -42.6% | -22.8% | |
| – | +103.1% | +50.6% | +127.3% | +18.9% | – | – | – | |
| – | +82.3% | -84.0% | +68.3% | +30.5% | +61.9% | +8.6% | +65.0% | |
| – | +97.6% | +135.3% | +68.8% | +13.0% | +0.6% | +17.5% | +106.7% | |
| – | – | – | – | +5.3% | -19.2% | +82.3% | +1.6% | |
| – | +44.9% | +98.6% | +100.0% | -13.6% | -32.4% | +68.8% | -48.5% | |
| – | – | – | +34.7% | -31.6% | +21.3% | -44.6% | -47.8% | |
| – | – | – | – | – | – | – | – | |
| – | +1,955.4% | +34.9% | +8.9% | -0.5% | +27.4% | +25.6% | +1.5% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.